ScreenerHero

EXOZ eXoZymes, Inc.

NAS · US · Healthcare · Biotechnology · exozymes.com
5.540USD+0.36%Mkt Cap: 51.55M $P/E: —

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap51.55M USD
Enterprise Value46.67M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.16M USD
Revenue/Share—
Last Price5.540 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees32
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.55
EV/Revenue—
P/S—
P/B14.01
EPS (TTM)-1.19
EPS (Forward)—
52W Range
4.3508% of range18.40
52W High18.40 USD
52W Low4.350 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-269.59%
ROA-153.37%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.50M USD
CapEx (TTM)169.92K USD
FCF Margin—
FCF Yield-6.31%
Net Debt-4.57M USD
Net Debt/EBITDA0.45
Balance Sheet
Debt/Equity0.37
Current Ratio3.81
Quick Ratio3.63
Book Value/Sh0.39 USD
Cash/Share0.61 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.30M
Float7.17M
Insiders65.35%
Institutions1.34%
Short Interest
Short Ratio3.6d
Short % Float0.41%
Short % Out.0.22%
Shares Short20.42K
Short (prev mo.)19.52K
Technical
SMA 506.039 (-8.3%)
SMA 2008.400 (-34.0%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)6.26K
Avg Vol (10d)5.69K
Technical Indicators
RSI (14)36.5
MACD-0.2126
MACD Signal-0.1324
MACD Hist.-0.0802
BB Upper6.700 USD
BB Middle6.072 USD
BB Lower5.445 USD
BB Width20.67%
ATR (14)0.4382 USD
Vol Ratio (20d)1.02x